The present invention provides modified oligomeric compounds that modulate gene expression via an RNA interference pathway. The oligomeric compounds of the invention include one or more cross-linkages that can improve nuclease resistance or modify or enhance the pharmacokinetic and phamacodynamic properties of the oligomeric compound.
本发明提供了通过 RNA 干扰途径调节
基因表达的改性低聚化合物。本发明的低聚化合物包括一种或多种交联,可提高
核酸酶抗性或改变或增强低聚化合物的药代动力学和药效学特性。